Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia |
| |
Authors: | Mohamed Uwais Napolitano Carlo Priori Silvia G |
| |
Institution: | From the Division of Cardiology, Department of Medicine, London Health Science Centre, London, Canada;;Department of Molecular Cardiology, I.R.C.C.S. Fondazione S. Maugeri;;and Department of Cardiology, University of Pavia, Pavia, Italy |
| |
Abstract: | Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmogenic disorder characterized by adrenergically mediated polymorphic ventricular tachyarrhythmias. Genetic investigations have identified two variants of the disease: an autosomal dominant form associated with mutations in the gene encoding the cardiac ryanodine receptor (RyR2) and a recessive form associated with homozygous mutations in the gene encoding the cardiac isoform of calsequestrin (CASQ2). Functional characterization of mutations identified in the RyR2 and CASQ2 genes has demonstrated that CPVT are caused by derangements of the control of intracellular calcium. Investigations in a knock-in mouse model have shown that CPVT arrhythmias are initiated by delayed afterdepolarizations and triggered activity. In the present article, we review clinical and molecular understanding of CPVT and discuss the most recent approaches to develop novel therapeutic strategies for the disease. |
| |
Keywords: | arrhythmias sudden cardiac death adrenergic activity genetics ventricular tachycardia |
本文献已被 PubMed 等数据库收录! |
|